> top > docs > PubMed:27003763 > annotations

PubMed:27003763 JSONTXT

Annnotations TAB JSON ListView MergeView

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-76 Sentence denotes Efficacy of L-arginine for preventing preeclampsia in high-risk pregnancies:
TextSentencer_T2 77-120 Sentence denotes A double-blind, randomized, clinical trial.
TextSentencer_T3 121-131 Sentence denotes OBJECTIVE:
TextSentencer_T4 132-244 Sentence denotes This study aimed to estimate the effectiveness of L-arginine for preventing preeclampsia in high-risk pregnancy.
TextSentencer_T5 245-253 Sentence denotes METHODS:
TextSentencer_T6 254-382 Sentence denotes We performed a randomized, double-blind, placebo-controlled, clinical trial in patients with high-risk factors for preeclampsia.
TextSentencer_T7 383-461 Sentence denotes Fifty subjects received L-arginine, beginning from the 20th week of gestation.
TextSentencer_T8 462-517 Sentence denotes An additional 50 patients received homologated placebo.
TextSentencer_T9 518-526 Sentence denotes RESULTS:
TextSentencer_T10 527-650 Sentence denotes The placebo group had a higher number of cases of preeclampsia (11/47) compared with the L-arginine group (3/49, P = 0.01).
TextSentencer_T11 651-759 Sentence denotes Birth weight was higher in the L-arginine group and there was a smaller number of preterm births (P = 0.03).
TextSentencer_T12 760-824 Sentence denotes CONCLUSION: L-arginine is effective for preventing preeclampsia.
T1 0-76 Sentence denotes Efficacy of L-arginine for preventing preeclampsia in high-risk pregnancies:
T2 77-120 Sentence denotes A double-blind, randomized, clinical trial.
T3 121-131 Sentence denotes OBJECTIVE:
T4 132-244 Sentence denotes This study aimed to estimate the effectiveness of L-arginine for preventing preeclampsia in high-risk pregnancy.
T5 245-253 Sentence denotes METHODS:
T6 254-382 Sentence denotes We performed a randomized, double-blind, placebo-controlled, clinical trial in patients with high-risk factors for preeclampsia.
T7 383-461 Sentence denotes Fifty subjects received L-arginine, beginning from the 20th week of gestation.
T8 462-517 Sentence denotes An additional 50 patients received homologated placebo.
T9 518-526 Sentence denotes RESULTS:
T10 527-650 Sentence denotes The placebo group had a higher number of cases of preeclampsia (11/47) compared with the L-arginine group (3/49, P = 0.01).
T11 651-759 Sentence denotes Birth weight was higher in the L-arginine group and there was a smaller number of preterm births (P = 0.03).
T12 760-824 Sentence denotes CONCLUSION: L-arginine is effective for preventing preeclampsia.

Preeclampsia

Id Subject Object Predicate Lexical cue
PD-Preeclampsia-B_T1 38-50 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T2 208-220 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T3 369-381 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T4 577-589 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T5 811-823 ORPHA:275555 denotes preeclampsia

Preeclampsia-compare

Id Subject Object Predicate Lexical cue
PD-Preeclampsia-B_T1 38-50 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T2 208-220 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T3 369-381 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T4 577-589 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T5 811-823 ORPHA:275555 denotes preeclampsia

yangbin123xm_800_3

Id Subject Object Predicate Lexical cue
T1 12-22 CI denotes L-arginine
T12 509-516 CI denotes placebo
T14 531-538 CI denotes placebo
T2 182-192 CI denotes L-arginine
T3 407-417 CI denotes L-arginine
T4 616-626 CI denotes L-arginine
T5 682-692 CI denotes L-arginine
T6 772-782 CI denotes L-arginine

chenxin_473849_800_3

Id Subject Object Predicate Lexical cue
T1 12-22 CI denotes L-arginine
T2 182-192 CI denotes L-arginine
T3 407-417 CI denotes L-arginine
T4 616-626 CI denotes L-arginine
T5 682-692 CI denotes L-arginine
T6 772-782 CI denotes L-arginine
T8 531-538 CI denotes placebo
T9 509-516 CI denotes placebo